fda compounding semaglutide warning november 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded GLP-1 Drugs and Telehealth Providers FDA and Novo Nordisk Warn

Weeks 5 through 8 increase to 2mg once weekly

Hypoglycemia risk with Semaglutide / Cyanocobalamin Injection varies considerably depending on concurrent antidiabetic therapy

When asthma drug albuterol first went into a shortage earlier this year, hospitals compounded the drug to tailor it to each patient

Reduced Cardiovascular Risk Hashimotos is associated with higher cholesterol and increased cardiovascular risk

Published clinical studies have evaluated investigational retatrutide under controlled research conditions, but those findings should not be interpreted as evidence that this research product is approved for patient care

After reconstitution Once you add bacteriostatic water, the clock starts ticking